BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24302998)

  • 21. Multifunctional human CD56 low CD16 low natural killer cells are the prominent subset in bone marrow of both healthy pediatric donors and leukemic patients.
    Stabile H; Nisti P; Morrone S; Pagliara D; Bertaina A; Locatelli F; Santoni A; Gismondi A
    Haematologica; 2015 Apr; 100(4):489-98. PubMed ID: 25596273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two patients with Hermansky Pudlak syndrome type 2 and novel mutations in AP3B1.
    Wenham M; Grieve S; Cummins M; Jones ML; Booth S; Kilner R; Ancliff PJ; Griffiths GM; Mumford AD
    Haematologica; 2010 Feb; 95(2):333-7. PubMed ID: 19679886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel insights from adaptor protein 3 complex deficiency.
    Badolato R; Parolini S
    J Allergy Clin Immunol; 2007 Oct; 120(4):735-41; quiz 742-3. PubMed ID: 17931556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus.
    Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF
    Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus.
    Guo H; Xu B; Gao L; Sun X; Qu X; Li X; Liu S; Feng J; Wang J; Tang Y; Yan G; Gao X; Jiang Y
    Exp Biol Med (Maywood); 2012 May; 237(5):556-62. PubMed ID: 22547395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD56
    Ma M; Yin X; Zhao X; Guo C; Zhu X; Liu T; Yang M; Zhang Z; Fu Y; Liu J; Xu J; Ding H; Han X; Chu Z; Shang H; Jiang Y
    J Leukoc Biol; 2019 Dec; 106(6):1313-1323. PubMed ID: 31483071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel AP3B1 compound heterozygous mutations in a Japanese patient with Hermansky-Pudlak syndrome type 2.
    Nishikawa T; Okamura K; Moriyama M; Watanabe K; Ibusuki A; Sameshima S; Masamoto I; Yamazaki I; Tanita K; Kanekura T; Kanegane H; Suzuki T; Kawano Y
    J Dermatol; 2020 Feb; 47(2):185-189. PubMed ID: 31820501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
    Pierson BA; Miller JS
    Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD56
    Jaime P; García-Guerrero N; Estella R; Pardo J; García-Álvarez F; Martinez-Lostao L
    Osteoarthritis Cartilage; 2017 Oct; 25(10):1708-1718. PubMed ID: 28668542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct natural killer cells in HIV-exposed seronegative subjects with effector cytotoxic CD56(dim) and CD56(bright) cells and memory-like CD57⁺NKG2C⁺CD56(dim) cells.
    Lima JF; Oliveira LM; Pereira NZ; Mitsunari GE; Duarte AJ; Sato MN
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):463-71. PubMed ID: 25230289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD56
    Kariminia A; Ivison S; Ng B; Rozmus J; Sung S; Varshney A; Aljurf M; Lachance S; Walker I; Toze C; Lipton J; Lee SJ; Szer J; Doocey R; Lewis I; Smith C; Chaudhri N; Levings MK; Broady R; Devins G; Szwajcer D; Foley R; Mostafavi S; Pavletic S; Wall DA; Couban S; Panzarella T; Schultz KR
    Haematologica; 2017 Nov; 102(11):1936-1946. PubMed ID: 28935847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impairment of dendritic cell functions in patients with adaptor protein-3 complex deficiency.
    Prandini A; Salvi V; Colombo F; Moratto D; Lorenzi L; Vermi W; De Francesco MA; Notarangelo LD; Porta F; Plebani A; Facchetti F; Sozzani S; Badolato R
    Blood; 2016 Jun; 127(26):3382-6. PubMed ID: 27207797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential alteration of CD56(bright) and CD56 (dim) natural killer cells in frequency, phenotype, and cytokine response in chronic hepatitis C virus infection.
    Miyagi T; Shimizu S; Tatsumi T; Nishio K; Hiramatsu N; Kanto T; Hayashi N; Takehara T
    J Gastroenterol; 2011 Aug; 46(8):1020-30. PubMed ID: 21559771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12.
    Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C
    Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial hemophagocytic lymphohistiocytosis: a model for understanding the human machinery of cellular cytotoxicity.
    Sieni E; Cetica V; Mastrodicasa E; Pende D; Moretta L; Griffiths G; Aricò M
    Cell Mol Life Sci; 2012 Jan; 69(1):29-40. PubMed ID: 21990010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.